Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
INCY News
Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript April 30, 2024 Incyte Corporation misses on earnings expectations. Reported EPS is $0.746 EPS...
Incyte Corporation INCY reported first-quarter 2024 adjusted earnings of 64 cents per share, which missed the Zacks Consensus Estimate of 88 cents. The company...
April 30 (Reuters) - Incyte Corp on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug Jakafi, sending its...
Analyst ratings
52%
of 25 ratingsMore INCY News
For the quarter ended March 2024, Incyte (INCY) reported revenue of $880.89 million, up 8.9% over the same period last year. EPS came in at $0.64, compared to $...
WILMINGTON, Del. (AP) — WILMINGTON, Del. (AP) — Incyte Corp. (INCY) on Tuesday reported first-quarter profit of $169.5 million. On a per-share basis, the Wilmi...
For Immediate Release Chicago, IL – April 26, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...
